IRVINE, Calif., Oct. 26 /PRNewswire/ -- ISTA Pharmaceuticals, Inc. today announced that it will release third quarter 2005 financial results on November 8, 2005 before the U.S. markets open. ISTA will host a conference call with a simultaneous webcast to discuss these results at 10:30 a.m. Eastern Time on November 8, 2005.
To access the live conference call, U.S. and Canadian participants may dial 800-322-5044; international participants may dial 617-614-4927. To access the 24-hour audio replay, U.S. and Canadian participants may dial 888-286-8010; international participants may dial 617-801-6888. The access code for the call is 54897893. This conference call will also be webcast live and archived on ISTA’s Web site for 30 days at http://www.istavision.com.
ABOUT ISTA
ISTA is a specialty pharmaceutical company focused on the development and commercialization of unique and uniquely improved ophthalmic products. ISTA’s products and product candidates seek to address serious diseases and conditions of the eye such as dry eye, vitreous hemorrhage, diabetic retinopathy, hyphema, glaucoma, ocular pain and inflammation. Building on this pipeline, ISTA’s goal is to continue its growth as a specialty pharmaceutical company by acquiring complementary products, either already marketed or in late-stage development. For more information, please visit the company’s Web site at http://www.istavision.com.
ISTA Pharmaceuticals, Inc.
CONTACT: Vince Anido, +1-949-788-5311, vanido@istavision.com, or LaurenSilvernail, +1-949-788-5302, lsilvernail@istavision.com, both of ISTAPharmaceuticals, or media, Justin Jackson, +1-212-213-0006,jjackson@burnsmc.com, or, investors, Lisa Burns or Laura Siino,+1-212-213-0006, lsiino@burnsmc.com, all of Burns McClellan
Web site: http://www.istavision.com/
